NOT KNOWN FACTS ABOUT MKENA.COM

CDER’s latest proposal to withdraw the accelerated acceptance of Makena (HPC) was based mostly on a significant randomized trial that failed to substantiate the good thing about this drug to newborns or decrease the chance of PTB. In building the decision to suggest Makena’s withdrawal, CDER also reviewed outcomes from prior reports of proges